Speakers
Faheem Ahmed, M.D.
Managing Partner
Metaphys Capital
Dave Allen, Ph.D.
Director of Translation
The Francis Crick Institute
Jeroen Bakker, Ph.D.
Partner
Novo Holdings Seed Investments
Matt Barnes, Ph.D.
Chief Scientific Officer and President
Nxera Pharma UK
Susie Barnes, MRCGP FFPM
SVP, Head of Global Medical Affairs, Vaccines
GSK
Steve Bates
CEO
BIA (U.K. BioIndustry Association)
Joshua Berlin
Head of Corporate Alliances & Business Development
BioCentury Inc.
Joanna Betts, Ph.D.
Executive Director & Head of Applied and Translational Omics
GSK
Kate Bingham
Managing Partner
SV Health Investors
David Bredt, M.D., Ph.D.
Founder, Chief Scientific Officer
Rapport Therapeutics
Peter Campbell, Ph.D.
Academic Co-Founder & Chief Scientific Officer
Quotient Therapeutics
Jacques Carolan, Ph.D.
Programme Director
ARIA
Carmine Circelli
Director of Life Sciences
British Business Bank
Sarah Cole, Ph.D.
CEO
SENISCA Ltd.
Miles Congreve, Ph.D.
Chief Scientific Officer
Isomorphic Labs
James Critchley, Ph.D.
Managing Director
PJT Partners
Lee Cronin, Ph.D.
CEO, Chemify and Regius Professor of Chemistry
University of Glasgow
Liane Dupont, Ph.D.
Associate
Lundbeckfonden BioCapital
Kevin Eggan, Ph.D.
Professor, Harvard Stem Cell Institute & Head of Research and Early Development
Biomarin Pharmaceutical
Margarete Fabre, Ph.D.
Oncology Lead, Centre for Genomics Research
AstraZeneca
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Gernot Füchsel, Ph.D.
Client Engagement Lead
Kipu Quantum
Shaun Grady
Chair, U.K.
AstraZeneca
Anika Gupta, Ph.D.
Principal
GV
Stephen Hansen
Director of Biopharma Intelligence
BioCentury Inc.
Masato Hata, Ph.D.
Deputy Head of Research Institute Munich, Oncology Lead
Daiichi Sankyo Europe
Chris Hollowood, Ph.D.
CEO
Syncona
Jonathan Hopper, Ph.D.,
Founder & VP, Platforms
Omass Therpaeutics
Anne Horgan, Ph.D.
Partner
Cambridge Innovation Capital (CIC)
Layla Hosseini-Gerami, Ph.D.
Co-Founder & Chief Data Science Officer
Ignota Labs
Joanna Howson, Ph.D.
SVP, Innovation and Data Experimentation Advancement
Novo Nordisk
Steve Jackson, Ph.D.
Professor of Biology, Cambridge and Group Leader
CRUK-CI, University of Cambridge
Annalisa Jenkins, MBBS FRCP
Non-Executive Director
LetterOne
Pierre Joffrin
Senior Associate
Syncona
Michelle Jones, Ph.D.
Chief Operating Officer
Astex Pharmaceuticals
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Sophie Kornowski, Pharm.D.
Former CEO
Boston Pharmaceuticals
Guru Laxmikanthan, Ph.D.
Partner
Nutter McClennen & Fish LLP
Alex Leech
Partner
Sofinnova Partners
John Lepore, M.D.
President & CEO
ProFound Therapeutics
Jing Liang, Ph.D.
Managing Partner
Umbrex
Husseini Manji, M.D.
Professor
Oxford and Yale Universities, UK Govt Mental Health Mission
Justine McIlroy, Ph.D.
Partner
Coulter Partners
Marianne Mertens, Ph.D.
Partner
Apollo Health Ventures
Andrew Miles
Chief Business Officer
Our Future Health UK
Graham Mills, Ph.D.
Principal
Abingworth
Rachel Moss, Ph.D.
Senior Partner
McKinsey & Company
Viet Pham Ngoc, Ph.D.
Quantum Software Engineer
Infleqtion UK
Paul Nioi, Ph.D.
SVP, Research
Alnylam Pharmaceuticals
Stephen O'Rahilly, M.D.
Professor of Clinical Biochemistry and Medicine
University of Cambridge
Jane Osbourn, Ph.D.
CEO
Alchemab Therapeutics Ltd.
Slavé Petrovski, Ph.D.
VP, Centre for Genomics Research
AstraZeneca
Kiran Reddy, M.D.
Senior Managing Director
Blackstone
Kendra Rose, Ph.D.
SVP Head of Cell & Gene Therapy BD&L
Bayer
Martin Rutter, M.D.
Deputy Chief Scientist
UK Biobank
Kristin-Anne Rutter
Executive Director
Cambridge University Health Partners (CUHP)
James Sabry, M.D., Ph.D.
EVP & Chief Business Officer
BioMarin Pharmaceutical Inc.
Regina Salvat, Ph.D.
Principal
Forbion
Valentina Sartori
Partner
McKinsey & Company
Alex Schuth, M.D.
Chief Operating and Financial Officer
Denali Therapeutics
Joost Schymkowitz, Ph.D.
Vice-Director
VIB Neuroscience Leuven
Staša Stanković, Ph.D.
Co-founder & CEO
OvartiX
Anastasiya Sybirna, Ph.D.
Senior Associate
F-Prime Capital
Victoria Taylor
Associate
Medicxi
Sarah Teichmann, PH.D.
Professor & Chair
Cambridge Stem Cell Institute & GSK
Morgan Thelander
Chief Operating Officer
J.Thelander Consulting
Jody Thelander
Founder & CEO
J.Thelander Consulting
Simon Turner
Partner
Sofinnova Partners
Patrick Vallance, KCB
Minister of State for Science, Research and Innovation
Department for Science, Innovation and Technology
Jérôme Van Biervliet, Ph.D.
Managing Director
VIB
Jean-Philippe Vert, Ph.D.
CEO
Bioptimus
Alice Vickers, Ph.D.
Director, Business Development & Search and Evaluation
Verdiva Bio
Amber Vodegel
Founder & CEO
28x
Annelise Vuidepot, Ph.D.
SVP, CTO, Research and UK Site Lead
Immunocore Holdings plc
Michael White
Head of Life Sciences
HSBC Innovation Banking
Maziar Zarrehparvar
Fund Advisor
Kurma Partners